| Product: | Cordycepin | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | 17425 | ||||||||
| CAS Number: | 73-03-0 | ||||||||
| Synonyms: | 3’-Deoxyadenosine | ||||||||
| Pricing: |
| ||||||||
| Formula: | C10H13N5O3 | ||||||||
| Molecular Weight: | 251.24 | ||||||||
| Structure: |  | ||||||||
| Appearance: | White powder | ||||||||
| Category: | Anti-cancer compounds | ||||||||
| Stability: | Stable under recommended storage conditions | ||||||||
| Storage: | Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C | ||||||||
| Transportation: | IATA: Hazard Class: 6.1; UN Number: UN2811; Packing Group: III; Shipping Name: Toxic solid, organic, n.o.s. (3’-Deoxyadenosine) | ||||||||
| Literature References: | Duncan, R.F., Cordycepin blocks recovery of non-heat-shock mRNA translation following heat shock in Drosophila. Eur. J. Biochem. 233, 784-792, (1995); Ioannidis, P., et al., The polyadenylation inhibitor cordycepin (3"dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels. Oncogene 18, 117-125, (1999); Kodama, E.N., et al., Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells. Biochem. Pharmacol. 59, 273-281, (2000); Lloyd, A.L., et al., Genomic Islands Of Uropathogenic Escherichia Coli Contribute To Virulence. J. Bacteriol. 191, 3469-81, (2009); Merck 14,2529; Beil. 26,IV,3594 | ||||||||
| MSDS: | |||||||||
| Description: | Cordycepin is an adenosine analogue that is readily converted to cordycepin 5′-triphosphate; can be used for 3′-end labeling of RNA |
